Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 5, Number 1—February 1999

The Economic Impact of Staphylococcus aureus Infection in New York City Hospitals

Robert J. Rubin, Catherine A. Harrington, Anna Poon, Kimberly Dietrich, Jeremy A. Greene, and Adil Moiduddin
Author affiliations: The Lewin Group, Fairfax, Virginia, USA

Main Article

Table 3

Incidence of Staphylococcus aureus infections from research or clinical panel

Type of infection Description S. aureus % Reference
Bacteremia Staphylococcal septicemia 50 30
Bacteremia 15 31,32
Infection and inflammatory reaction due to internal vascular device, implant, and graft 16 4
Endocarditis Acute and subacute bacterial endocarditis 30 Clinical panel
Infection and inflammatory reaction due to cardiac device, implant, and graft 14 33
Surgical site infection Disruption of operation wound and postoperative infection 20 4
Osteomyelitis Acute and chronic osteomyelitis 50 34,35
Septic arthritis Pyogenic arthritis 11 (age <5 yr) 33
33 (age 5-18 yr)
55 (age >18 yr)
Infection and inflammatory reaction due to internal joint prosthesis 25 33

Main Article

Page created: December 07, 2010
Page updated: December 07, 2010
Page reviewed: December 07, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.